HEADER LIPID TRANSPORT 07-APR-11 2LBV TITLE SIDEROCALIN Q83 REVEALS A DUAL LIGAND BINDING MODE COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXTRACELLULAR FATTY ACID-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EX-FABP, LIPOCALIN Q83; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: COTURNIX JAPONICA; SOURCE 3 ORGANISM_COMMON: JAPANESE QUAIL; SOURCE 4 ORGANISM_TAXID: 93934; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET3D KEYWDS LIPOCALIN, SIDEROCALIN, ENTEROBACTIN, ARACHIDONIC ACID, LIPID KEYWDS 2 TRANSPORT EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR N.COUDEVYLLE,M.HOETZINGER,L.GEIST,G.KONTAXIS,K.BISTER,R.KONRAT REVDAT 1 22-FEB-12 2LBV 0 JRNL AUTH N.COUDEVYLLE,M.HOETZINGER,L.GEIST,G.KONTAXIS,M.HARTL, JRNL AUTH 2 K.BISTER,R.KONRAT JRNL TITL LIPOCALIN Q83 REVEALS A DUAL LIGAND BINDING MODE WITH JRNL TITL 2 POTENTIAL IMPLICATIONS FOR THE FUNCTIONS OF SIDEROCALINS JRNL REF BIOCHEMISTRY V. 50 9192 2011 JRNL REFN ISSN 0006-2960 JRNL PMID 21951132 JRNL DOI 10.1021/BI201115Q REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LBV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-APR-11. REMARK 100 THE RCSB ID CODE IS RCSB102205. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM [U-100% 13C; U-100% 15N] REMARK 210 Q83-1, 1MM ENTEROBACTIN-2, 1MM REMARK 210 GALLIUM(III)-3, 1MM ARACHIDONIC REMARK 210 ACID-4, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCO; 3D REMARK 210 CBCA(CO)NH; 3D HNCA; 3D HNCACB; REMARK 210 3D HN(CO)CA; 3D HCCH-TOCSY; 3D REMARK 210 HNHA; 3D 1H-15N NOESY; 3D 1H-13C REMARK 210 NOESY ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H TRP A 13 O ALA A 37 1.47 REMARK 500 O ALA A 17 H LEU A 114 1.48 REMARK 500 O GLY A 43 H GLU A 46 1.57 REMARK 500 O LYS A 67 O TYR A 77 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 12 110.31 -162.57 REMARK 500 1 ALA A 17 134.41 -175.85 REMARK 500 1 THR A 69 76.73 -107.74 REMARK 500 1 SER A 70 9.32 -159.16 REMARK 500 1 ASP A 71 -83.22 -51.29 REMARK 500 1 LYS A 82 57.56 30.46 REMARK 500 1 VAL A 87 101.41 -55.55 REMARK 500 1 ASP A 89 124.43 179.16 REMARK 500 1 TYR A 92 3.22 52.43 REMARK 500 1 SER A 94 -21.20 -154.78 REMARK 500 1 PRO A 119 -22.01 -37.30 REMARK 500 1 GLN A 149 125.72 -36.61 REMARK 500 1 GLU A 156 22.56 -77.82 REMARK 500 2 PRO A 4 159.70 -36.64 REMARK 500 2 LYS A 12 110.44 -164.71 REMARK 500 2 ALA A 17 137.54 -179.49 REMARK 500 2 PRO A 56 -20.76 -38.58 REMARK 500 2 ASP A 71 -49.85 -19.99 REMARK 500 2 ASP A 72 66.38 -164.77 REMARK 500 2 VAL A 87 96.21 -59.09 REMARK 500 2 ASP A 89 121.01 -178.80 REMARK 500 2 LYS A 93 -24.81 -154.03 REMARK 500 2 SER A 94 -57.23 -126.95 REMARK 500 2 ASP A 105 106.06 -58.86 REMARK 500 2 PRO A 119 19.76 -66.52 REMARK 500 3 PRO A 4 139.71 -36.45 REMARK 500 3 LYS A 12 111.06 -165.61 REMARK 500 3 ALA A 17 135.76 -179.48 REMARK 500 3 PRO A 56 -19.95 -38.85 REMARK 500 3 ASP A 71 -48.90 -19.61 REMARK 500 3 ASP A 72 65.99 -164.24 REMARK 500 3 LYS A 82 62.29 37.07 REMARK 500 3 VAL A 87 96.06 -59.68 REMARK 500 3 ASP A 89 121.22 -178.94 REMARK 500 3 LYS A 93 -22.28 -154.35 REMARK 500 3 SER A 94 -57.06 -130.62 REMARK 500 3 ASP A 105 108.21 -59.26 REMARK 500 3 PRO A 119 -22.12 -37.60 REMARK 500 4 LYS A 12 110.18 -163.88 REMARK 500 4 ALA A 17 139.14 179.51 REMARK 500 4 LYS A 55 87.53 -162.11 REMARK 500 4 PRO A 56 -20.84 -37.36 REMARK 500 4 ASP A 71 -46.66 -21.08 REMARK 500 4 ASP A 72 87.18 -175.42 REMARK 500 4 LYS A 82 60.92 35.93 REMARK 500 4 VAL A 87 95.62 -60.56 REMARK 500 4 ASP A 89 120.56 -179.57 REMARK 500 4 LYS A 93 -29.96 -155.39 REMARK 500 4 SER A 94 -60.14 -120.01 REMARK 500 4 ASP A 105 107.27 -59.13 REMARK 500 REMARK 500 THIS ENTRY HAS 277 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 1 GA A 201 GA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 EB4 A 200 O5 REMARK 620 2 EB4 A 200 O3 138.0 REMARK 620 3 EB4 A 200 O1 133.8 85.3 REMARK 620 4 EB4 A 200 O4 79.6 126.9 84.2 REMARK 620 5 EB4 A 200 O6 74.2 84.3 138.9 71.0 REMARK 620 6 EB4 A 200 O2 87.2 76.5 89.9 155.0 125.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EB4 A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GA A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACD A 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17577 RELATED DB: BMRB DBREF 2LBV A 2 157 UNP Q9I9P7 EXFAB_COTJA 23 178 SEQADV 2LBV MET A 1 UNP Q9I9P7 EXPRESSION TAG SEQRES 1 A 157 MET THR VAL PRO ASP ARG SER GLU ILE ALA GLY LYS TRP SEQRES 2 A 157 TYR VAL VAL ALA LEU ALA SER ASN THR GLU PHE PHE LEU SEQRES 3 A 157 ARG GLU LYS ASP LYS MET LYS MET ALA MET ALA ARG ILE SEQRES 4 A 157 SER PHE LEU GLY GLU ASP GLU LEU LYS VAL SER TYR ALA SEQRES 5 A 157 VAL PRO LYS PRO ASN GLY CYS ARG LYS TRP GLU THR THR SEQRES 6 A 157 PHE LYS LYS THR SER ASP ASP GLY GLU VAL TYR TYR SER SEQRES 7 A 157 GLU GLU ALA LYS LYS LYS VAL GLU VAL LEU ASP THR ASP SEQRES 8 A 157 TYR LYS SER TYR ALA VAL ILE TYR ALA THR ARG VAL LYS SEQRES 9 A 157 ASP GLY ARG THR LEU HIS MET MET ARG LEU TYR SER ARG SEQRES 10 A 157 SER PRO GLU VAL SER PRO ALA ALA THR ALA ILE PHE ARG SEQRES 11 A 157 LYS LEU ALA GLY GLU ARG ASN TYR THR ASP GLU MET VAL SEQRES 12 A 157 ALA MET LEU PRO ARG GLN GLU GLU CYS THR VAL ASP GLU SEQRES 13 A 157 VAL HET EB4 A 200 69 HET GA A 201 1 HET ACD A 300 53 HETNAM EB4 N,N',N''-[(3S,7S,11S)-2,6,10-TRIOXO-1,5,9- HETNAM 2 EB4 TRIOXACYCLODODECANE-3,7,11-TRIYL]TRIS(2,3- HETNAM 3 EB4 DIHYDROXYBENZAMIDE) HETNAM GA GALLIUM (III) ION HETNAM ACD ARACHIDONIC ACID HETSYN EB4 ENTEROBACTIN FORMUL 2 EB4 C30 H27 N3 O15 FORMUL 3 GA GA 3+ FORMUL 4 ACD C20 H32 O2 HELIX 1 1 VAL A 3 ALA A 10 1 8 HELIX 2 2 THR A 22 ASP A 30 1 9 HELIX 3 3 SER A 122 ARG A 136 1 15 HELIX 4 4 THR A 139 GLU A 141 5 3 SHEET 1 A10 VAL A 143 MET A 145 0 SHEET 2 A10 TRP A 13 ALA A 19 -1 N LEU A 18 O ALA A 144 SHEET 3 A10 MET A 111 SER A 116 -1 O LEU A 114 N ALA A 17 SHEET 4 A10 TYR A 95 ARG A 102 -1 N ALA A 100 O MET A 111 SHEET 5 A10 LYS A 83 THR A 90 -1 N ASP A 89 O VAL A 97 SHEET 6 A10 VAL A 75 SER A 78 -1 N TYR A 76 O VAL A 85 SHEET 7 A10 ARG A 60 LYS A 67 -1 N LYS A 67 O TYR A 77 SHEET 8 A10 GLU A 46 VAL A 53 -1 N LEU A 47 O PHE A 66 SHEET 9 A10 ALA A 35 GLY A 43 -1 N GLY A 43 O GLU A 46 SHEET 10 A10 TRP A 13 ALA A 19 -1 N TRP A 13 O ALA A 37 SSBOND 1 CYS A 59 CYS A 152 1555 1555 2.02 LINK O5 EB4 A 200 GA GA A 201 1555 1555 1.74 LINK O3 EB4 A 200 GA GA A 201 1555 1555 1.84 LINK O1 EB4 A 200 GA GA A 201 1555 1555 1.87 LINK O4 EB4 A 200 GA GA A 201 1555 1555 1.88 LINK O6 EB4 A 200 GA GA A 201 1555 1555 1.94 LINK O2 EB4 A 200 GA GA A 201 1555 1555 1.95 SITE 1 AC1 11 PHE A 25 MET A 32 TYR A 51 VAL A 53 SITE 2 AC1 11 TRP A 62 LYS A 83 ARG A 102 LEU A 109 SITE 3 AC1 11 MET A 111 GA A 201 ACD A 300 SITE 1 AC2 1 EB4 A 200 SITE 1 AC3 13 TRP A 13 ALA A 37 ILE A 39 PHE A 41 SITE 2 AC3 13 VAL A 49 SER A 50 TYR A 51 VAL A 85 SITE 3 AC3 13 TYR A 92 ILE A 98 ARG A 113 TYR A 115 SITE 4 AC3 13 EB4 A 200 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 185 0 3 4 10 0 8 6 0 0 0 13 END